Saturday, April 20, 2024

Daniel Shortt

Daniel is a corporate and regulatory attorney based in Seattle, Washington who works extensively with entrepreneurs in the cannabis industry. He advises clients on matters related to both hemp and marijuana, and frequently speaks on legal issues relating to cannabis across the country and abroad.

other Featured Stories

Posts

The FDA’s Problem With Hemp-CBD

The lack of public trust in the FDA helps inform the current problem it faces with CBD oil.

Congress Lays Out Expectations For FDA On Hemp-CBD

The report is kind of a big deal because it outlines Congress’ expectations for the Food and Drug Administration (“FDA”) when it comes to Hemp-CBD.

Did The 2018 Farm Bill Open The Door To Importing Hemp?

We get a ton of questions about whether it’s legal to import hemp into the U.S. It’s a complicated question without a clear answer.

Topical CBD: The FDA Stance On Hemp Derived CBD In Cosmetics

Before looking closely at FDA’s answer there, it’s important to understand how the FDA defines cosmetics.

USPS Guidance On Mailing Hemp and CBD Products

Recently the United States Post Office issued an advisory on “Acceptance Criteria for Cannabidiol (CBD) Oil and Products Containing CBD.

Federal Court Denies Review Of DEA’s Marijuana Extract Rule

Last week, the US Court of Appeals for the Ninth Circuit denied a lawsuit challenging the Drug Enforcement Administration’s (DEA) controversial Marihuana Extracts Rule.

Don't Miss Your Weekly Dose of The Fresh Toast.

Stay informed with exclusive news briefs delivered directly to your inbox every Friday.

We respect your privacy. Unsubscribe anytime.